Early rule-out and rule-in strategies for myocardial infarction

Clinical Chemistry

Volumn 63, Issue 1, 2017, Pages 129-139

  Cullen, Louise A ^a   Mills, Nicholas L ^b   Mahler, Simon ^c   Body, Richard ^d  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TROPONIN;

ACUTE CORONARY SYNDROME; CARDIOVASCULAR DISEASE ASSESSMENT; CLINICAL DECISION MAKING; CLINICAL TRIAL (TOPIC); CONTROL STRATEGY; CORONARY RISK; EVIDENCE BASED PRACTICE; GRACE SCORE; HEART INFARCTION; HEART SCORE; HUMAN; MEDICAL INFORMATION; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW (TOPIC); TIMI RISK SCORE; ACUTE DISEASE; ALGORITHM; MYOCARDIAL INFARCTION;

ACUTE DISEASE; ALGORITHMS; BIOMARKERS; HUMANS; MYOCARDIAL INFARCTION; TROPONIN;

EID: 85008448624     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2016.254730     Document Type: Review

References (78)

1. Goodacre S. The health care burden of acute chest pain. Heart 2005;91:229-30.
2. Pope JH, Aufderheide TP, Ruthazer R, Woolard RH, Feldman JA, Beshansky JR, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000;342:1163-70.
3. Cullen L, Greenslade J, Merollini K, Graves N, Hammett CJ, Hawkins T, et al. Cost and outcomes of assessing patients with chest pain in an Australian emergency department. Med J Aust 2015;202:427-32.
4. Fanaroff AC, Rymer JA, Goldstein SA, Simel DL, Newby LK. Does this patient with chest pain have acute coronary syndrome?: the Rational Clinical Examination Systematic Review. JAMA 2015;314:1955-65.
5. Body R, Cook G, Burrows G, Carley S, Lewis PS. Can emergency physicians 'rule in' and 'rule out' acute myocardial infarction with clinical judgement? Emerg Med J 2014;31:872-6.
6. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Circulation 2012;126:2020-35.
7. Body R, McDowell G, Carley S, Wibberley C, Ferguson J, Mackway-Jones K. A FABP-ulous 'rule out' strategy? Heart fatty acid binding protein and troponin for rapid exclusion of acute myocardial infarction. Resuscitation 2011;82:1041-6.
8. Wildi K, Zellweger C, Twerenbold R, Jaeger C, Reichlin T, Haaf P, et al. Incremental value of copeptin to highly sensitive cardiac Troponin I for rapid rule-out of myocardial infarction. Int J Cardiol 2015;190:170-6.
9. McCann CJ, Glover BM, Menown IB, Moore MJ, McEneny J, Owens CG, et al. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. Eur Heart J 2008;29:2843-50.
10. Than M, Herbert M, Flaws D, Cullen L, Hess E, Hollander JE, et al. What is an acceptable risk of major adverse cardiac event in chest pain patients soon after discharge from the Emergency Department?: a clinical survey. Int J Cardiol 2013;166:752-4.
11. Pierce MA, Hess EP, Kline JA, Shah ND, Breslin M, Branda ME, et al. The Chest Pain Choice trial: a pilot randomized trial of a decision aid for patients with chest pain in the emergency department. Trials 2010;11:57.
12. Skinner JS, Smeeth L, Kendall JM, Adams PC, Timmis A, Chest Pain Guideline Development G. NICE guidance. Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin. Heart 2010;96:974-8.
13. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 2012;58:1574-81.
14. Apple FS, Collinson PO, Biomarkers ITFoCAoC. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012;58:54-61.
15. National Institute for Health and Care Excellence (NICE). Myocardial infarction (acute): early rule out using high-sensitivity troponin tests (Elecsys Troponin T high-sensitive, ARCHITECT STAT High Sensitive Troponin-I and AccuTnI+3 assays): DG15. London: National Institute for Health and Care Excellence; 2014. https://www.nice.org.uk/guidance/dg15 (Accessed May 2016).
16. Sandoval Y, Apple FS. The global need to define normality: the 99th percentile value of cardiac troponin. Clin Chem 2014;60:455-62.
17. Westwood M, van Asselt T, Ramaekers B, Whiting P, Thokala P, Joore M, et al. High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysis. Health Technol Assess 2015;19:1-234.
18. Melki D, Lind S, Agewall S, Jernberg T. Diagnostic value of high sensitive troponin T in chest pain patients with no persistent ST-elevations. Scand Cardiovasc J 2011;45:198-204.
19. Aldous SJ, Richards M, Cullen L, Troughton R, Than M. Diagnostic and prognostic utility of early measurement with high-sensitivity troponin T assay in patients presenting with chest pain. CMAJ 2012;184:E260-8.
20. Keller T, Zeller T, Ojeda F, Tzikas S, Lillpopp L, Sinning C, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011;306:2684-93.
21. Pickering JW, Greenslade JH, Cullen L, Flaws D, Parsonage W, George P, et al. Validation of presentation and 3 h high-sensitivity troponin to rule-in and rule-out acute myocardial infarction. Heart 2016;102:1270-8.
22. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent STSegment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016;37:267-315.
23. Body R, Carley S, McDowell G, Jaffe AS, France M, Cruickshank K, et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol 2011;58:1332-9.
24. Rubini Gimenez M, Hoeller R, Reichlin T, Zellweger C, Twerenbold R, Reiter M, et al. Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin. Int J Cardiol 2013;168:3896-901.
25. Bandstein N, Ljung R, Johansson M, Holzmann MJ. Undetectable high-sensitivity cardiac troponin T level in the emergency department and risk of myocardial infarction. J Am Coll Cardiol 2014;63:2569-78.
26. Zhelev Z, Hyde C, Youngman E, Rogers M, Fleming S, Slade T, et al. Diagnostic accuracy of single baseline measurement of Elecsys Troponin T high-sensitive assay for diagnosis of acute myocardial infarction in emergency department: systematic review and metaanalysis. BMJ 2015;350:h15.
27. Shah AS, Anand A, Sandoval Y, Lee KK, Smith SW, Adamson PD, et al. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet 2015;386:2481-8.
28. Reichlin T, Schindler C, Drexler B, Twerenbold R, Reiter M, Zellweger C, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arc Intern Med 2012;172:1211-8.
29. Mueller C, Giannitsis E, Christ M, Ordonez-Llanos J, de-Filippi C, McCord J, et al. Multicenter evaluation of a 0-hour/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T. Ann Emerg Med 2016;68:76-87 e74.
30. Body R, Mueller C, Giannitsis E, Christ M, Ordonez-Llanos J, de Filippi CR, et al. The use of very low concentrations of high sensitivity troponin T to rule out acute myocardial infarction using a single blood test. Acad Emerg Med 2016;23:1004-13.
31. Rubini Gimenez M, Twerenbold R, Jaeger C, Schindler C, Puelacher C, Wildi K, et al. One-hour rule-in and ruleout of acute myocardial infarction using highsensitivity cardiac troponin I. Am J Med 2015;128:861-70. e4.
32. Parsonage WA, Tate JR, Greenslade JH, Hammett CJ, Ungerer JP, Pretorius CJ, et al. Effect of recalibration of the hs-TnT assay on diagnostic performance. Clin Chem Lab Med 2014;52:e25-7.
33. Wildi K, Twerenbold R, Jaeger C, Rubini Gimenez M, Reichlin T, Stoll M, et al. Clinical impact of the 2010-2012 low-end shift of high-sensitivity cardiac troponin T. Eur Heart J Acute Cardiovasc Care [Epub ahead of print 2016 Apr. 7].
34. McCord J, Nowak RM, McCullough PA, Foreback C, Borzak S, Tokarski G, et al. Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-ofcare testing of myoglobin and troponin I. Circulation 2001;104:1483-8.
35. Than M, Cullen L, Reid CM, Lim SH, Aldous S, Ardagh MW, et al. A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study. Lancet 2011;377:1077-84.
36. Than M, Cullen L, Aldous S, Parsonage WA, Reid CM, Greenslade J, et al. 2-Hour Accelerated Diagnostic Protocol to Assess Patients With Chest Pain Symptoms Using Contemporary Troponins as the Only Biomarker: the ADAPT trial. J Am Coll Cardiol 2012;59:2091-8.
37. Goodacre SW, Bradburn M, Cross E, Collinson P, Gray A, Hall AS, et al. The Randomised Assessment of Treatment using Panel Assay of Cardiac Markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. Heart 2011;97:190-6.
38. Fitzgerald P, Goodacre SW, Cross E, Dixon S. Costeffectiveness of point-of-care biomarker assessment for suspected myocardial infarction: the randomized assessment of treatment using panel Assay of cardiac markers (RATPAC) trial. Acad Emerg Med 2011;18:488-95.
39. Glatz JF, Vork MM, van der Vusse GJ. Significance of cytoplasmic fatty acid-binding protein for the ischemic heart. Mol Cell Biochem 1993;123:167-73.
40. Glatz JF, van Bilsen M, Paulussen RJ, Veerkamp JH, van der Vusse GJ, Reneman RS. Release of fatty acidbinding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim Biophys Acta 1988;961:148-52.
41. Kilcullen N, Viswanathan K, Das R, Morrell C, Farrin A, Barth JH, et al. Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values. J Am Coll Cardiol 2007;50:2061-7.
42. Lippi G, Mattiuzzi C, Cervellin G. Critical review and meta-analysis on the combination of heart-type fatty acid binding protein (H-FABP) and troponin for early diagnosis of acute myocardial infarction. Clin Biochem 2013;46:26-30.
43. Inoue K, Suwa S, Ohta H, Itoh S, Maruyama S, Masuda N, et al. Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain. Circ J 2011;75:2813-20.
44. Body R, Carley S, McDowell G, Pemberton P, Burrows G, Cook G, et al. The Manchester Acute Coronary Syndromes (MACS) decision rule for suspected cardiac chest pain: derivation and external validation. Heart 2014;100:1462-8.
45. Carlton E, Body R, Greaves K. External Validation of the Manchester Acute Coronary Syndromes Decision Rule. Acad Emerg Med 2016;23:136-43.
46. Body R. Reducing unnecessary admissions for chest pain with the Manchester Acute Coronary Syndromes (MACS) decision rule. 2013. www.isrctn. com/isrctn86818215 (Accessed April 2016).
47. Lipinski MJ, Escarcega RO, D'Ascenzo F, Magalhaes MA, Baker NC, Torguson R, et al. A systematic review and collaborative meta-analysis to determine the incremental value of copeptin for rapid rule-out of acute myocardial infarction. Am J Cardiol 2014;113:1581-91.
48. Raskovalova T, Twerenbold R, Collinson PO, Keller T, Bouvaist H, Folli C, et al. Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care 2014;3:18-27.
49. Thelin J, Borna C, Erlinge D, Öhlin B. The combination of high sensitivity troponin T and copeptin facilitates early rule-out of ACS: a prospective observational study. BMC Cardiovasc Disord 2013;13:42.
50. Mockel M, Searle J, Hamm C, Slagman A, Blankenberg S, Huber K, et al. Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study. Eur Heart J 2015;36(6):369-76.
51. Mahler SA, Miller CD, Hollander JE, Nagurney JT, Birkhahn R, Singer AJ, et al. Identifying patients for early discharge: performance of decision rules among patients with acute chest pain. Int J Cardiol 2013;168:795-802.
52. Cullen L, Mueller C, Parsonage WA, Wildi K, Greenslade JH, Twerenbold R, et al. Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol 2013;62:1242-9.
53. O'Connor RE, Al Ali AS, Brady WJ, Ghaemmaghami CA, Menon V, Welsford M, et al. Part 9: Acute Coronary Syndromes: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2015;132(18 Suppl 2):S483-500.
54. Antman EM, McCabe CH, Gurfinkel EP, Turpie AG, Bernink PJ, Salein D, et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Qwave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation 1999;100:1593-601.
55. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000;284:835-42.
56. Cohen M, Demers C, Gurfinkel EP, Turpie AG, Fromell GJ, Goodman S, et al. A comparison of low-molecularweight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med 1997;337:447-52.
57. Pollack CV, Jr., Sites FD, Shofer FS, Sease KL, Hollander JE. Application of the TIMI risk score for unstable angina and non-ST elevation acute coronary syndrome to an unselected emergency department chest pain population. Acad Emerg Med 2006;13:13-8.
58. Hess EP, Agarwal D, Chandra S, Murad MH, Erwin PJ, Hollander JE, et al. Diagnostic accuracy of the TIMI risk score in patients with chest pain in the emergency department: a meta-analysis. CMAJ 2010;182:1039-44.
59. Investigators G. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J 2001;141:190-9.
60. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003;163:2345-53.
61. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004;291:2727-33.
62. Lyon R, Morris AC, Caesar D, Gray S, Gray A. Chest pain presenting to the Emergency Department- to stratify risk with GRACE or TIMI? Resuscitation 2007;74:90-3.
63. Than M, Aldous S, Lord SJ, Goodacre S, Frampton CM, Troughton R, et al. A 2-hour diagnostic protocol for possible cardiac chest pain in the emergency department: a randomized clinical trial. JAMA Intern Med 2014;174:51-8.
64. Mahler SA, Miller CD, Litt HI, Gatsonis CA, Snyder BS, Hollander JE. Performance of the 2-hour accelerated diagnostic protocol within the American College of Radiology Imaging Network PA 4005 cohort. Acad Emerg Med 2015;22:452-60.
65. Six AJ, Backus BE, Kelder JC. Chest pain in the emergency room: value of the HEART score. Neth Heart J 2008;16(6):191-6.
66. Backus BE, Six AJ, Kelder JC, Mast TP, van den Akker F, Mast EG, et al. Chest pain in the emergency room: a multicenter validation of the HEART Score. Crit Pathw Cardiol 2010;9:164-9.
67. Backus BE, Six AJ, Kelder JC, Bosschaert MA, Mast EG, Mosterd A, et al. A prospective validation of the HEART score for chest pain patients at the emergency department. Int J Cardiol 2013;168:2153-8.
68. Six AJ, Cullen L, Backus BE, Greenslade J, Parsonage W, Aldous S, et al. The HEART score for the assessment of patients with chest pain in the emergency department: a multinational validation study. Crit Pathw Cardiol 2013;12:121-6.
69. Mahler SA, Hiestand BC, Goff DC, Jr., Hoekstra JW, Miller CD. Can the HEART score safely reduce stress testing and cardiac imaging in patients at low risk for major adverse cardiac events? Crit Pathw Cardiol 2011;10:128-33.
70. Mahler SA, Riley RF, Hiestand BC, Russell GB, Hoekstra JW, Lefebvre CW, et al. The HEART pathway randomized trial: identifying emergency department patients with acute chest pain for early discharge. Circ Cardiovasc Qual Outcomes 2015;8:195-203.
71. Than M, Flaws D, Sanders S, Doust J, Glasziou P, Kline J, et al. Development and validation of the Emergency Department Assessment of Chest pain Score and 2 h accelerated diagnostic protocol. Emerg Med Australas 2014;26:34-44.
72. Cullen L, Greenslade JH, Than M, Brown AF, Hammett CJ, Lamanna A, et al. The new Vancouver Chest Pain Rule using troponin as the only biomarker: an external validation study. Am J Emerg Med 2014;32:129-34.
73. Greenslade JH, Cullen L, Than M, Aldous S, Chu K, Brown AF, et al. Validation of the Vancouver Chest Pain Rule using troponin as the only biomarker: a prospective cohort study. Am J Emerg Med 2013;31:1103-7.
74. Mokhtari A, Borna C, Gilje P, Tyden P, Lindahl B, Nilsson HJ, et al. A 1-h combination algorithm allows fast ruleout and rule-in of major adverse cardiac events. J Am Coll Cardiol 2016;67:1531-40.
75. Poldervaart JM. Risk stratification in chest pain patients [Dissertation]. UMC Repository: Utrecht University; 2016.
76. George T, Ashover S, Cullen L, Larsen P, Gibson J, Bilesky J, et al. Introduction of an accelerated diagnostic protocol in the assessment of emergency department patients with possible acute coronary syndrome: the Nambour Short Low-Intermediate Chest pain project. Emerg Med Australas 2013;25:340-4.
77. Queensland Government, Queensland Health. Healthcare Improvement Unit: the Accelerated Chest Pain Risk Evaluation (ACRE) Project. Queensland Health; 2015. https://www.health.qld.gov. au/caru/html/acre. asp (Accessed September 2016).
78. Than MP, Pickering JW, Aldous SJ, Cullen L, Frampton CM, Peacock WF, et al. Effectiveness of EDACS versus ADAPT accelerated diagnostic pathways for chest pain: a pragmatic randomized controlled trial embedded within practice. Ann Emerg Med 2016;68:93-102.